<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05612165</url>
  </required_header>
  <id_info>
    <org_study_id>03-2022-001</org_study_id>
    <nct_id>NCT05612165</nct_id>
  </id_info>
  <brief_title>Effectiveness and Safety of tDCS for Pain</brief_title>
  <official_title>Effectiveness and Safety of Transcranial Direct Current Stimulation for Pain Changes in Patients With Central Post-Stroke Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pusan National University Yangsan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pusan National University Yangsan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to verify the effectiveness and safty of transcranial direct&#xD;
      current stimulation in patients with central post-stroke pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 9, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of pain score in Brief Pain Inventory(BPI)</measure>
    <time_frame>Baseline, after 2 weeks, and 1 month after the end of intervention</time_frame>
    <description>Brief Pain Inventory(BPI) is used for measurement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of pain score in Neuropathic Pain Scale(NPS)</measure>
    <time_frame>Baseline, after 2 weeks, and 1 month after the end of intervention</time_frame>
    <description>Neuropathic Pain Scale(NPS) is used for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of depression score in Beck Depression Inventory-II(BDI-II)</measure>
    <time_frame>Baseline, after 2 weeks, and 1 month after the end of intervention</time_frame>
    <description>Beck Depression Inventory-II(BDI-II) is used for measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of quality of life score in EQ-5D-3L</measure>
    <time_frame>Baseline, after 2 weeks, and 1 month after the end of intervention</time_frame>
    <description>EQ-5D-3L is used for measurement.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Pain, Chronic</condition>
  <arm_group>
    <arm_group_label>tDCS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Direct Current Stimulation(tDCS)</intervention_name>
    <description>The tDCS intervention was conducted for 20 minutes(1000μA) each time, 5 times a week for 2 weeks, a total of 10 times.</description>
    <arm_group_label>tDCS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Transcranial Direct Current Stimulation(sham tDCS)</intervention_name>
    <description>The sham tDCS intervention was conducted for 20 minutes(0μA) each time, 5 times a week for 2 weeks, a total of 10 times.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults aged 19 to 90 years old&#xD;
&#xD;
          2. Those who have been diagnosed with first-time stroke through doctors' clinical&#xD;
             observation and brain imaging diagnosis&#xD;
&#xD;
          3. A person whose stroke lesions are cortex or subcortex&#xD;
&#xD;
          4. A person who satisfies 'Mandatory criteria'&#xD;
&#xD;
          5. Those with cognitive ability to understand and follow the researcher's instructions&#xD;
&#xD;
          6. Those who voluntarily agree to participate in this clinical trial and signed the&#xD;
             agreement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Those who have a fracture or have undergone orthopedic surgery&#xD;
&#xD;
          2. In case of accompanying serious neurological diseases&#xD;
&#xD;
          3. In case of major psychiatric diseases such as major depression disorders,&#xD;
             schizophrenia, bipolar disorders, and dementia&#xD;
&#xD;
          4. Those with complex part pain syndrome by Budapest Criteria&#xD;
&#xD;
          5. If there is a cause of other pain in the relevant area, such as peripheral nerve&#xD;
             damage&#xD;
&#xD;
          6. Persons included in the exclusion of transcranial direct current stimulation&#xD;
&#xD;
          7. If the researcher is judged to be judged that the participation in this study is not&#xD;
             appropriate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>JISOO BAIK</last_name>
    <phone>+82553604159</phone>
    <email>zisoo@pusan.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pusan national university Yangsan Hospital</name>
      <address>
        <city>Gyeongsang</city>
        <state>Yangsan</state>
        <zip>50610</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youjin Jeong</last_name>
      <email>ctccrc@pnuyh.co.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 3, 2022</study_first_submitted>
  <study_first_submitted_qc>November 3, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2022</study_first_posted>
  <last_update_submitted>November 3, 2022</last_update_submitted>
  <last_update_submitted_qc>November 3, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pusan National University Yangsan Hospital</investigator_affiliation>
    <investigator_full_name>Yong-il Shin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

